The Role of Migraine Prophylaxis Agent Topiramate in Treating Patients With Sudden Sensorineural Hearing Loss
Clinical trial NCT05403229 · UNKNOWN
Trial details
- NCT number
- NCT05403229
- Sponsor
- Chang Gung Memorial Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-17
- Primary completion
- 2025-05-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.